About Crestone, Inc.
One of the Leading Biotech Companies in Colorado

Crestone, Inc. is a clinical stage biopharmaceutical & biotech company in Boulder, Colorado focused on inventing and research for developing novel mechanism of action small molecule drugs for serious bacterial infections such as C. difficile.

Company

Overview

Meet

Our Team

Read our

Code of Ethics

Browse

Careers

Company Overview

Boulder-based Crestone, Inc. is a clinical stage biotech company focused on inventing and developing novel mechanism of action small molecule drugs for serious bacterial infections. Its pipeline includes antibacterial agents that work against antimicrobial resistance to treat CDI, resistant Gram-positive infections such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE), and chronic infections such as nontuberculous mycobacterial (NTM) disease.

Our Team

Crestone is a team of scientists with experience in the areas of synthetic organic chemistry, process chemistry, analytical chemistry, microbiology, cell biology, biochemistry, and pharmacology. As one of the leading research pharmaceutical companies in Colorado, we take a team-based approach to solving challenging problems and are passionate about making a real difference with our work.

Crestone biotech company in Boulder, Colorado team members in a lab doing C. difficile research.

Code of Ethics

A company’s reputation for integrity is its most valuable asset and is directly related to the conduct of its officers and other employees. Follow the link below to read our code of ethics.

Become a Part of Our Projects

Interested in helping further our research into novel antibacterial agents? We’d be thrilled to have your help, either as an investor or a team member at our biotech company.

Inquiries

Have a question or comment? Follow the link below to contact us about general inquiries.

Careers

Find work in a team-oriented environment at one of the leading Colorado pharma companies.

Investors

If you're interested in becoming an investor to help fund our research and development, contact us today.